Subscribe
Operational gearing and profit upgrade potential.
Phil Oakley analyses the quality of growth at a corporate payments company and private medical services provider
These energy mainstays are undergoing massive change.
The investment thesis has changed significantly for both a dividend stalwart and a leading housebuilder, says Robin Hardy
A past-maligned stock on a good run, or a former stalwart in a rut - which is the best buy?
How sustainable are these seemingly robust dividend payments?
These US companies will be ripe to re-rate once Fed policy eases.
Well-executed business models in structural growth markets.
Some stocks may be technically undervalued but it is right that more risk is priced in.
Phil Oakley examines a re-rate story and an AI support play.
